149 related articles for article (PubMed ID: 31602755)
1. Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.
Jung HH; Lee S
Diabetes Obes Metab; 2020 Feb; 22(2):243-253. PubMed ID: 31602755
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.
Jung HH
JAMA Netw Open; 2021 Sep; 4(9):e2127387. PubMed ID: 34586368
[TBL] [Abstract][Full Text] [Related]
3. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
Lee JH; Han K; Huh JH
Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157
[TBL] [Abstract][Full Text] [Related]
4. Long-term glycemic control relates to mortality in type II diabetes.
Andersson DK; Svärdsudd K
Diabetes Care; 1995 Dec; 18(12):1534-43. PubMed ID: 8722048
[TBL] [Abstract][Full Text] [Related]
5. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Effect of Early Versus Delayed Metformin Treatment on Glycaemic Parameters Among Australian Adults With Incident Diabetes: Evidence Using a National General Practice Database.
Zheng M; Begum M; Bernardo CO; Stocks N; Gonzalez-Chica D
Clin Ther; 2024 May; 46(5):396-403. PubMed ID: 38565499
[TBL] [Abstract][Full Text] [Related]
7. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
8. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
Schneider B; Martin S; Heinemann L; Lodwig V; Kolb H
Arzneimittelforschung; 2007; 57(12):762-9. PubMed ID: 18380408
[TBL] [Abstract][Full Text] [Related]
9. Association between fasting blood glucose and intracranial cerebral artery stenosis: a secondary analysis based on a retrospective cross-sectional study in Korean adults.
Wu D; Xu D; Ye F; Xu N; Yao T; Liao M
Acta Diabetol; 2021 Jun; 58(6):749-757. PubMed ID: 33555394
[TBL] [Abstract][Full Text] [Related]
10. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
[TBL] [Abstract][Full Text] [Related]
11. Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival.
Currie CJ; Holden SE; Jenkins-Jones S; Morgan CL; Voss B; Rajpathak SN; Alemayehu B; Peters JR; Engel SS
Diabetes Obes Metab; 2018 Apr; 20(4):821-830. PubMed ID: 29119713
[TBL] [Abstract][Full Text] [Related]
12. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
13. Association between fasting blood glucose and outcomes and mortality in acute ischaemic stroke patients with diabetes mellitus: a retrospective observational study in Wuhan, China.
Yao T; Zhan Y; Shen J; Xu L; Peng B; Cui Q; Liu Z
BMJ Open; 2020 Jun; 10(6):e037291. PubMed ID: 32580989
[TBL] [Abstract][Full Text] [Related]
14. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
[TBL] [Abstract][Full Text] [Related]
15. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
16. The association between blood glucose value and long-term mortality.
Wändell PE; Theobald H
Diabetes Metab; 2005 Dec; 31(6):588-94. PubMed ID: 16357808
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
18. Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality.
Kim SM; Lee G; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Kim SG; Hwang SS; Park SY; Kim YY; Park SM
Diabetologia; 2020 Nov; 63(11):2305-2314. PubMed ID: 32820349
[TBL] [Abstract][Full Text] [Related]
19. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
[TBL] [Abstract][Full Text] [Related]
20. Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults.
Jung MH; Yi SW; An SJ; Balkau B; Yi JJ; Kim H
Diabetologia; 2020 Aug; 63(8):1616-1625. PubMed ID: 32424541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
